AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32087745 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial processes and intervention
Number of subjects: 64
Study 32087745 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse effects
Number of subjects: 64
Study 33332873 — intervention group
Group type: EXPERIMENTAL
Intervention: Open synthetic mesh
Number of subjects: 253
Study 33332873 — intervention group
Group type: EXPERIMENTAL
Intervention: Open biological mesh
Number of subjects: 253
Study 33332873 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic synthetic mesh
Number of subjects: 253
Study 33332873 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic biological mesh
Number of subjects: 253
Study 33332873 — intervention group
Group type: COMPARATOR
Intervention: Biological mesh (overall)
Number of subjects: 253
Study 32315965 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin exercise
Number of subjects: 61
Study 32315965 — intervention group
Group type: COMPARATOR
Intervention: Brisk walking
Number of subjects: 61
Study 35531961 — intervention group
Group type: EXPERIMENTAL
Intervention: Newborn Behavioral Observations (NBO) plus treatment as usual (TAU)
Number of subjects: 74
Study 35531961 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) only
Number of subjects: 74
Study 34898918 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% Triphala mouthwash
Number of subjects: 72
Study 34898918 — intervention group
Group type: COMPARATOR
Intervention: 0.12% chlorhexidine mouthwash
Number of subjects: 72
Study 34910093 — intervention group
Group type: EXPERIMENTAL
Intervention: HYPE + CAT
Number of subjects: 139
Study 34910093 — intervention group
Group type: EXPERIMENTAL
Intervention: HYPE + befriending
Number of subjects: 139
Study 34910093 — intervention group
Group type: COMPARATOR
Intervention: YMHS + befriending
Number of subjects: 139
Study 34910093 — intervention group
Group type: COMPARATOR
Intervention: HYPE + CAT vs befriending
Number of subjects: 139
Study 34910093 — intervention group
Group type: COMPARATOR
Intervention: HYPE vs YMHS + befriending
Number of subjects: 139
Study 34910093 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 139
Study 34728746 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable device
Number of subjects: 0
Study 34728746 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone
Number of subjects: 0
Study 35421875 — intervention group
Group type: EXPERIMENTAL
Intervention: Zheng‐Yi‐Fang (ZYF)
Number of subjects: 0
Study 35421875 — intervention group
Group type: COMPARATOR
Intervention: Regular western medicine (Control)
Number of subjects: 0
Study 33990249 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 188
Study 32845329 — intervention group
Group type: COMPARATOR
Intervention: NIH or US government agency-sponsored trials
Number of subjects: 245999
Study 32845329 — intervention group
Group type: COMPARATOR
Intervention: Industry-sponsored trials
Number of subjects: 245999
Study 32845329 — intervention group
Group type: COMPARATOR
Intervention: Other sources-sponsored trials
Number of subjects: 245999
Study 616122612 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg t.i.d for 1 month
Number of subjects: 13
Study 616122612 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 36155516 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin®
Number of subjects: 116
Study 36155516 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 116
Study 36155516 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 116
Study 36155516 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 116
Study 33501510 — intervention group
Group type: EXPERIMENTAL
Intervention: Dominant hand
Number of subjects: 60
Study 33501510 — intervention group
Group type: COMPARATOR
Intervention: Non-dominant hand
Number of subjects: 60
Study 33501510 — intervention group
Group type: EXPERIMENTAL
Intervention: Both hands
Number of subjects: 60
Study 32101857 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined high-intensity interval training (2-week duration)
Number of subjects: 0
Study 32101857 — intervention group
Group type: COMPARATOR
Intervention: Routine lifestyle (control group)
Number of subjects: 0
Study 35882451 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 individual biobehaviourally informed, app‐facilitated, multicomponent telerehabilitation sessions with a licenced physical therapist (n=29)
Number of subjects: 44
Study 35882451 — intervention group
Group type: COMPARATOR
Intervention: Education on exercise and COVID‐19 recovery trajectory, physical activity and vitals monitoring, and weekly check‐ins with study staff (n=15)
Number of subjects: 44
Study 33402333 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in the number of RCTs by 5% for each 10% increase in disability-adjusted life years (DALYs) for a health condition (3.2%-6.9%).
Number of subjects: 463000
Study 33402333 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditions like respiratory infections and tuberculosis had 7000 RCTs below predicted numbers based on disease burden.
Number of subjects: 463000
Study 33402333 — intervention group
Group type: EXPERIMENTAL
Intervention: Each 10% shift in DALYs towards low and middle socioeconomic development countries was associated with a 4% reduction in RCTs (3.7%-4.9%).
Number of subjects: 463000
Study 36057478 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocabado's 6 × 6 exercises
Number of subjects: 58
Study 36057478 — intervention group
Group type: COMPARATOR
Intervention: Self-care program
Number of subjects: 58
Study 33546748 — intervention group
Group type: EXPERIMENTAL
Intervention: 650-nm invasive laser acupuncture (ILA)
Number of subjects: 45
Study 33546748 — intervention group
Group type: EXPERIMENTAL
Intervention: 830-nm invasive laser acupuncture (ILA)
Number of subjects: 45
Study 33546748 — intervention group
Group type: COMPARATOR
Intervention: Real electroacupuncture (EA)
Number of subjects: 45
Study 33546748 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean version of the Oswestry Disability Index
Number of subjects: 45
Study 33546748 — intervention group
Group type: EXPERIMENTAL
Intervention: European Quality of Life Five Dimension Five Level scale
Number of subjects: 45
Study 35320216 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality exercises with routine physical therapy
Number of subjects: 84
Study 35320216 — intervention group
Group type: COMPARATOR
Intervention: Routine physical therapy
Number of subjects: 84
Study 32657136 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP (Pre-Exposure Prophylaxis)
Number of subjects: 370
Study 36344629 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of mirabegron and solifenacin
Number of subjects: 219
Study 36344629 — intervention group
Group type: COMPARATOR
Intervention: Solifenacin therapy (Control)
Number of subjects: 219
Study 32366577 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure (SBP) lowering (<120 mmHg) in the standard glycemic control arm
Number of subjects: 4731
Study 32366577 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure (SBP) lowering (<120 mmHg) in the intensive glycemic control arm
Number of subjects: 4731
Study 32366577 — intervention group
Group type: COMPARATOR
Intervention: Standard glycemic control
Number of subjects: 4731
Study 32366577 — intervention group
Group type: COMPARATOR
Intervention: Intensive glycemic control
Number of subjects: 4731
Study 35044166 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen-alone exposure
Number of subjects: 14
Study 35044166 — intervention group
Group type: EXPERIMENTAL
Intervention: DE and allergen coexposure
Number of subjects: 14
Study 35044166 — intervention group
Group type: EXPERIMENTAL
Intervention: Coexposure with particle-reducing technology
Number of subjects: 14
Study 35044166 — intervention group
Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 14
Study 33906634 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucinous tumors with mucus extension
Number of subjects: 152
Study 33906634 — intervention group
Group type: COMPARATOR
Intervention: Non-mucinous tumors
Number of subjects: 152
Study 32282706 — intervention group
Group type: EXPERIMENTAL
Intervention: Best standard of care plus cytokine adsorption during surgery while on cardiopulmonary bypass (protocol A)
Number of subjects: 54
Study 32282706 — intervention group
Group type: COMPARATOR
Intervention: Best standard of care alone, surgery without cytokine adsorption (protocol B)
Number of subjects: 54
Study 35849476 — intervention group
Group type: EXPERIMENTAL
Intervention: relugolix-combination therapy (relugolix-CT)
Number of subjects: 0
Study 35849476 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 34746417 — intervention group
Group type: EXPERIMENTAL
Intervention: PB-NHESC-C (autologous peripheral blood non-hematopoietic enriched stem cell cocktail)
Number of subjects: 139
Study 34746417 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 139
Study 34746417 — intervention group
Group type: EXPERIMENTAL
Intervention: PB-NHESC-C
Number of subjects: 139
Study 33038408 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomic regulation therapy (ART) utilizing cervical vagus nerve stimulation (VNS) for 6 months post-titration
Number of subjects: 60
Study 33038408 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomic regulation therapy (ART) utilizing cervical vagus nerve stimulation (VNS)
Number of subjects: 60
Study 35799657 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 times ED95 cis-atracurium (S1 group, 30 cases)
Number of subjects: 90
Study 35799657 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 times ED95 cis-atracurium (S2 group, 30 cases)
Number of subjects: 90
Study 35799657 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 times ED95 cis-atracurium (S3 group, 30 cases)
Number of subjects: 90
Study 35799657 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 times ED95 cis-atracurium (S2 group)
Number of subjects: 90
Study 35799657 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 times ED95 cis-atracurium (S3 group)
Number of subjects: 90
Study 35799657 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study 35799657 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 times ED95 cis-atracurium
Number of subjects: 90
Study 32990858 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections
Number of subjects: 44
Study 32990858 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (placebo) injections
Number of subjects: 44
Study 36286317 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-Support Ventilation (PSV)
Number of subjects: 969
Study 36286317 — intervention group
Group type: COMPARATOR
Intervention: T-Piece
Number of subjects: 969
Study 32380290 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Field Ablation (PFA)
Number of subjects: 80
Study 32380290 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency Ablation (RFA)
Number of subjects: 80
Study 36273168 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 104
Study 36273168 — intervention group
Group type: COMPARATOR
Intervention: Acarbose (ACA)
Number of subjects: 104
Study 34366347 — intervention group
Group type: EXPERIMENTAL
Intervention: Active high-definition transcranial direct current stimulation (HD-tDCS)
Number of subjects: 19
Study 34366347 — intervention group
Group type: COMPARATOR
Intervention: Sham high-definition transcranial direct current stimulation (HD-tDCS)
Number of subjects: 19
Study 35536390 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-assisted compression (PAC)
Number of subjects: 448
Study 35536390 — intervention group
Group type: COMPARATOR
Intervention: Standard compression (SC)
Number of subjects: 448
Study 34284317 — intervention group
Group type: EXPERIMENTAL
Intervention: Real air purification
Number of subjects: 57
Study 34284317 — intervention group
Group type: COMPARATOR
Intervention: Sham air purification
Number of subjects: 57
Study 35517991 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic ureteric stenting retrieval device
Number of subjects: 333
Study 35517991 — intervention group
Group type: COMPARATOR
Intervention: Conventional ureteral stent
Number of subjects: 333
Study 32662374 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch‐up (ABC) intervention
Number of subjects: 200
Study 32662374 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 200
Study 32882517 — intervention group
Group type: EXPERIMENTAL
Intervention: GEAR
Number of subjects: 19
Study 32882517 — intervention group
Group type: COMPARATOR
Intervention: Treadmill
Number of subjects: 19
Study 35354280 — intervention group
Group type: EXPERIMENTAL
Intervention: sintilimab + pemetrexed + platinum (SPP)
Number of subjects: 557
Study 35354280 — intervention group
Group type: COMPARATOR
Intervention: placebo + pemetrexed + platinum (PPP)
Number of subjects: 557
Study 33795299 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological mesh repair
Number of subjects: 140
Study 33795299 — intervention group
Group type: COMPARATOR
Intervention: Primary perineal wound closure
Number of subjects: 140
Study 33210178 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast (in vivo administration)
Number of subjects: 0
Study 33210178 — intervention group
Group type: COMPARATOR
Intervention: Control MSCs (C-MSCs)
Number of subjects: 0
Study 33210178 — intervention group
Group type: EXPERIMENTAL
Intervention: PsO-MSCs T0 (before treatment)
Number of subjects: 0
Study 33210178 — intervention group
Group type: EXPERIMENTAL
Intervention: PsO-MSCs T12 (after treatment)
Number of subjects: 0
Study 32210231 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic association with earlier male puberty timing
Number of subjects: 205354
Study 32210231 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analyses
Number of subjects: 205354
Study 32210231 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic correlation analysis
Number of subjects: 205354
Study 32210231 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of independent signals
Number of subjects: 205354
Study 32210231 — intervention group
Group type: EXPERIMENTAL
Intervention: Link between puberty timing and natural hair colour
Number of subjects: 205354
Study 33686446 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional laser-assisted topical corticosteroid delivery
Number of subjects: 19
Study 33686446 — intervention group
Group type: COMPARATOR
Intervention: Fractional laser monotherapy
Number of subjects: 19
Study 33686446 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study 33028554 — intervention group
Group type: EXPERIMENTAL
Intervention: IV contrast-enhanced CT
Number of subjects: 994
Study 33028554 — intervention group
Group type: COMPARATOR
Intervention: Native CT
Number of subjects: 994
Study 35842282 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofunctional Prosthetic System (BPS) complete dentures
Number of subjects: 16
Study 35842282 — intervention group
Group type: COMPARATOR
Intervention: Conventional complete dentures
Number of subjects: 16
Study 33691056 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% (1 mL)
Number of subjects: 40
Study 33691056 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (1 mg in 1 mL)
Number of subjects: 40
Study 32495646 — intervention group
Group type: EXPERIMENTAL
Intervention: MPTP + Environmental Enrichment (EE)
Number of subjects: 42
Study 34931854 — intervention group
Group type: EXPERIMENTAL
Intervention: Infographic
Number of subjects: 159
Study 34931854 — intervention group
Group type: EXPERIMENTAL
Intervention: Written summary
Number of subjects: 159
Study 34931854 — intervention group
Group type: COMPARATOR
Intervention: Video animation
Number of subjects: 159
Study 32306525 — intervention group
Group type: EXPERIMENTAL
Intervention: HSF™-based skin care formulation
Number of subjects: 32
Study 35569575 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Bias Modification (ABM)
Number of subjects: 61
Study 35569575 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 61
Study 32234533 — intervention group
Group type: EXPERIMENTAL
Intervention: Entrée portion sizes reduced to 90%, 85%, 80%, and 75% of the initial amount consumed in the first week.
Number of subjects: 81
Study 32234533 — intervention group
Group type: EXPERIMENTAL
Intervention: Entrée portion sizes at 80% and 75% reductions.
Number of subjects: 81
Study 32545143 — intervention group
Group type: EXPERIMENTAL
Intervention: Moringa leaf extract and iron capsules
Number of subjects: 40
Study 32545143 — intervention group
Group type: COMPARATOR
Intervention: Iron capsules
Number of subjects: 40
Study 34182233 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal HD-tDCS targeting the pDMN
Number of subjects: 84
Study 34182233 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal HD-tDCS targeting the aDMN
Number of subjects: 84
Study 34182233 — intervention group
Group type: COMPARATOR
Intervention: Sham HD-tDCS (Control)
Number of subjects: 84
Study 35216783 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based neurofunctional training (HBNFT)
Number of subjects: 30
Study 35216783 — intervention group
Group type: COMPARATOR
Intervention: Home-based resistance training (HBRT)
Number of subjects: 30
Study 33624731 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-based education and rehabilitation program (WERP)
Number of subjects: 140
Study 33624731 — intervention group
Group type: COMPARATOR
Intervention: Control care (CC)
Number of subjects: 140
Study 34425725 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-minute instructional video alone
Number of subjects: 62
Study 34425725 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-minute instructional video with video reflection intervention
Number of subjects: 62
Study 33997885 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone suppression test (DST) with method-specific cortisol cutoff of 2.4 µg/dL
Number of subjects: 400
Study 33997885 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone suppression test (DST) without method-specific cortisol cutoff
Number of subjects: 400
Study 33997885 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone <1.8 ng/mL in AI-ACS samples
Number of subjects: 400
Study 32310989 — intervention group
Group type: EXPERIMENTAL
Intervention: Stackelberg Game Theoretical Model for Load Balancing (SGMLB) algorithm
Number of subjects: 0
Study 35078116 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel (maximum dose: 12 mg/day)
Number of subjects: 97
Study 34004422 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated collaborative care intervention (I‐CARE)
Number of subjects: 108
Study 34004422 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 108
Study 35482347 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental agent (cancer drug)
Number of subjects: 24806
Study 35482347 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted drugs
Number of subjects: 24806
Study 35482347 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy drugs
Number of subjects: 24806
Study 35482347 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-immunotherapy-targeted drugs
Number of subjects: 24806
Study 35482347 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 24806
Study 33325793 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone (IVD) implant
Number of subjects: 52
Study 33325793 — intervention group
Group type: COMPARATOR
Intervention: Control group (no IVD implant)
Number of subjects: 52
Study 33325793 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IVD and control)
Number of subjects: 52
Study 34286526 — intervention group
Group type: EXPERIMENTAL
Intervention: New health education pathway for echinococcosis control
Number of subjects: 975
Study 34286526 — intervention group
Group type: COMPARATOR
Intervention: Routine health education (Control)
Number of subjects: 975
Study 33091102 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly audits of all ADC pockets
Number of subjects: 4
Study 33091102 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly audits of matrix (open pocket) drawers only
Number of subjects: 4
Study 33091102 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly audits of unassigned pockets only
Number of subjects: 4
Study 33091102 — intervention group
Group type: COMPARATOR
Intervention: No additional intervention
Number of subjects: 4
Study 36459910 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PTB) applied at pain points (G2) with a dose of 4 J and 6 J.
Number of subjects: 54
Study 36459910 — intervention group
Group type: COMPARATOR
Intervention: Photobiomodulation therapy (PTB) applied at pre-established points (G1) with a dose of 4 J and 6 J.
Number of subjects: 54
Study 34831764 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-sided games (SSGs) training program during Ramadan intermitting fasting (RIF), 4 weeks, 3 sessions per week
Number of subjects: 24
Study 34831764 — intervention group
Group type: COMPARATOR
Intervention: Active control group (CON), same SSG training program
Number of subjects: 24
Study 35014162 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade
Number of subjects: 38
Study 35014162 — intervention group
Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade
Number of subjects: 38
Study 33538902 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased blood pressure to 150 mmHg for 5 min using norepinephrine pump (0.05 μg/kg/min initial dose) after specimen extraction during ESD
Number of subjects: 309
Study 33538902 — intervention group
Group type: COMPARATOR
Intervention: Normal ESD
Number of subjects: 309
Study 34312043 — intervention group
Group type: EXPERIMENTAL
Intervention: SCT+HE (Standard Conservative Therapy plus Home Exercise)
Number of subjects: 0
Study 34312043 — intervention group
Group type: COMPARATOR
Intervention: SCT (Standard Conservative Therapy)
Number of subjects: 0
Study 32012958 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait retraining + minimalist shoe (GR)
Number of subjects: 30
Study 32012958 — intervention group
Group type: COMPARATOR
Intervention: Minimalist shoe (MIN)
Number of subjects: 30
Study 34352387 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized diet
Number of subjects: 135
Study 34352387 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized feedback
Number of subjects: 135